REQUEST A DEMO
Total
USD $0.00
Search more companies

Elite Pharma Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Elite Pharma Sas Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Elite Pharma Sas is an enterprise located in Colombia, with the main office in Bogota D.C.. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on February 03, 2016. It currently has a total number of 27 (2025) employees. The latest financial highlights indicate a net sales revenue increase of 107.9% in 2024. There was a total growth of 19.79% in Elite Pharma Sas’s total assets over the same period. The net profit margin of Elite Pharma Sas increased by 1.74% in 2024.

Headquarters
Cr 129 22B-57 In 21 Par Industrial De Occidente Fontibon Hb
Bogota D.C.; Bogota D.C; Postal Code: 0704

Contact Details: Purchase the Elite Pharma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Elite Pharma Sas report to view the information.
Financial Auditors:
Purchase the Elite Pharma Sas report to view the information.
Incorporation Date:
February 03, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Elite Pharma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
107.9%
Total operating revenue
107.9%
Operating profit (EBIT)
776.69%
Net Profit (Loss) for the Period
349.25%
Total Assets
19.79%
Total Equity
27.05%
Operating Profit Margin (ROS)
4.83%
Net Profit Margin
1.74%
Return on Equity (ROE)
15.4%
Quick Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?